FARSB
protein-codingphenylalanyl-tRNA synthetase subunit beta, the group of Aminoacyl tRNA synthetases, Class II
Gene summary
This gene encodes a highly conserved enzyme that belongs to the aminoacyl-tRNA synthetase class IIc subfamily. This enzyme comprises the regulatory beta subunits that form a tetramer with two catalytic alpha subunits. In the presence of ATP, this tetramer is responsible for attaching L-phenylalanine to the terminal adenosine of the appropriate tRNA. A pseudogene located on chromosome 10 has been identified. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2015]
- FARSLB
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~89.2 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0100215
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0100215
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0100215
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0100215
Submitter: Ambry Genetics
Clinical Genomic Database (CGD)
Manifestation: Cardiovascular; Craniofacial; Gastrointestinal; Musculoskeletal; Neurologic; Pulmonary; Renal
Intervention: Cardiovascular; Pulmonary
Rationale: The condition can include vascular aneurysms as well as severe lung disease, and awareness may allow prompt diagnosis and management; lung transplant has been described
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to FARSB variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_005687.5. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 39 | 3 | 43 | ||
| missense | 6 | 2 | 121 | 6 | 2 | 137 |
| nonsense | 2 | 2 | ||||
| start loss | 1 | 1 | ||||
| frameshift | 3 | 1 | 4 | |||
| splice donor/acceptor (+/-2bp) | 2 | 10 | 12 | |||
| Total | 9 | 5 | 135 | 45 | 5 | 199 |
Highest pathogenic variant AF is 0.000022318854
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_005678.3 | 17 | MANE Select | |
| Ensembl | ENSP00000281828.6 | 17 | MANE Select | |
| Ensembl | ENSP00000545171.1 | 18 | Standard | |
| Ensembl | ENSP00000545171.1 | 18 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Aminoacyl-tRNA biosynthesis - Homo sapiens (human)
- Phenylalanine and Tyrosine Metabolism
- Phenylketonuria
- Tyrosinemia Type 3 (TYRO3)
- Tyrosinemia Type 2 (or Richner-Hanhart syndrome)
Biological Process
- translation
- phenylalanyl-tRNA aminoacylation
- protein heterotetramerization
Molecular Function
- magnesium ion binding
- RNA binding
- phenylalanine-tRNA ligase activity
- protein binding
- ATP binding
Cellular Component
- cytoplasm
- cytosol
- phenylalanine-tRNA ligase complex
- membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000281828
- Coding exons
- 17
- Length
- 85802
- Individuals with no LoFs
- 125710
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 37
- Defined
- 125747
- p
- 0.000147
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 1.16 | 259 | 317 | 0.817 | 0.0000160 | 3858 |
| Missense (PolyPhen) | 51 | 91.698 | 0.55617 | 1140 | ||
| Synonymous | 0.716 | 103 | 113 | 0.914 | 0.00000600 | 1125 |
| Loss of Function | 3.43 | 10 | 30.4 | 0.329 | 0.00000167 | 384 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00032 | 0.00025 | rare |
| Latino/Admixed American | 0.000064 | 0.000058 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.00011 | 0.00011 | rare |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.00024 | 0.00023 | rare |
| South Asian | 0.000033 | 0.000033 | rare |
| Other | 0.00033 | 0.00033 | rare |
dbNSFP Gene Annotations
Source:
Recessive Scores
- pRec
- 0.153
Intolerance Scores
- LoFtool
- 0.279
- RVIS EVS
- -0.38
- RVIS percentile EVS
- 27.88
Essentials
- Essential (CRISPR)
- E
- Essential (CRISPR2)
- E
- Essential (gene trap)
- E
- Indispensability pred.
- E
- Indispensability score
- 0.996
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |